Announcements Trials
Browse Landscape

Phase

Phase 2 119Phase 1/2 28Phase 3 25Phase 1 17Phase NA 16Phase 4 10Phase EARLY_PHASE1 5Phase 2/3 1

Status

Completed 2Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2Sarcoma 1Gynecologic 1CNS 1

Conditions

Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, B-Cell 1Leukemia, Large Granular Lymphocytic 1Desmoplastic Small Round Cell Tumor 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Ifosfamide × Clear all
NCT03719105 2025-08-08

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

New York Medical College

Phase EARLY_PHASE1 Recruiting
40 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, T-Cell, Peripheral, Leukemia, Large Granular Lymphocytic

NCT04947501 2025-08-05

A Study of N9 Chemotherapy in Children With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Active not recruiting
26 enrolled
CNS

Neoplasms, Neuroblastoma

NCT00662233 2018-10-09

Combination Chemotherapy in Treating Patients With Sarcoma

Mayo Clinic

Phase EARLY_PHASE1 Completed
28 enrolled
GynecologicSarcoma

Ovarian Neoplasms, Sarcoma, Desmoplastic Small Round Cell Tumor

NCT01331590 2016-09-20

Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
13 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00515138 2012-04-12

A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant

University of California, San Francisco

Phase EARLY_PHASE1 Terminated
7 enrolled
Lymphoid

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡